Metachromatic leukodystrophy (MLD): management

Evidence-based neurology checklist on metachromatic leukodystrophy (mld): management: Magnetic resonance imaging (MRI): features White matter lesions Tigroid pattern Tumefactive lesions Thickening of the optic nerve Enhancement of the cranial nerves and cauda equina Other investigations Treatment

Magnetic resonance imaging (MRI): features

  • White matter lesions
  • Tigroid pattern
  • Tumefactive lesions
  • Thickening of the optic nerve
  • Enhancement of the cranial nerves and cauda equina

Other investigations

Treatment

References

  1. Meier K, Gärtner J, Huppke P. Tumefactive inflammatory lesions in juvenile metachromatic leukodystrophy. Neurol Neuroimmunol Neuroinflamm 2020; 8:e922. 
  2. Roi D, Mankad K, Kaliakatsos M, Cleary M, Manzur A, D'Arco F. Thickening of the optic nerves in metachromatic leucodystrophy: a new MRI finding. Neuroradiol J 2016; 29:134-136.
  3. Morana G, Biancheri R, Dirocco M, et al. Enhancing cranial nerves and cauda equina: an emerging magnetic resonance imaging pattern in metachromatic leukodystrophy and krabbe disease. Neuropediatrics 2009; 40:291-294.
  4. Beerepoot S, Nierkens S, Boelens JJ, Lindemans C, Bugiani M, Wolf NI. Peripheral neuropathy in metachromatic leukodystrophy: current status and future perspective. Orphanet J Rare Dis 2019; 14:240. 
  5. Cabanillas Stanchi KM, Böhringer J, et al. Hematopoietic stem cell transplantation with mesenchymal stromal cells in children with metachromatic leukodystrophy. Stem Cells Dev 2022; 31:163-175.
  6. And 3 more. Subscribe to see the full list

Related checklists

Loading...